The abstract is read at the publisher; the summary is JClub's.
Genome sequencing in 182 unrelated families with genetic skeletal disorders established molecular diagnoses in 134 families (73.6%), identifying 125 at first analysis (68.7%) plus nine more (4.9%).
- Why it matters: Genetic skeletal disorders have diverse clinical presentations and many remain undiagnosed; the study addresses how well genome sequencing plus careful clinical review can close that gap.
- What they did: Between 2015 and 2022, 186 pediatric and adult patients underwent short-read genome sequencing, with radiographs and clinical data reviewed using the 2023 International Nosology, followed by reassessment and reanalysis for unresolved cases.
- The result: The diagnostic yield was 68.7% initially and increased to 73.6% after reanalysis or family-based investigations, supporting genome sequencing as effective when paired with updated clinical and radiographic evaluation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.